NOTE 10 – STOCK WARRANTS

A summary of the status of the Company’s outstanding stock warrants and changes during the periods is presented below:

SCHEDULE OF WARRANT ACTIVITY

The fair value of stock warrants granted and vested during the three months ended March 31, 2026 was zero and $9,692, respectively.

The fair value of stock warrants granted and vested during the three months ended March 31, 2025 was zero and $389,179, respectively.

The following table summarizes information about stock warrants to purchase shares of the Company’s Class A common stock outstanding and exercisable as of March 31, 2025:

 SCHEDULE OF EXERCISABLE WARRANTS 

The compensation expense attributed to the issuance of the stock warrants is recognized as they are vested.

Total compensation expense related to the stock warrants was $9,692 and $389,179 for the three months ended March 31, 2026 and 2025, respectively, and was included in compensation expense on the condensed consolidated statement of operations. As of March 31, 2026, there was $16,796 in future compensation cost related to non-vested stock warrants which will be recognized over the remaining vesting period of approximately 0.4 years.

The aggregate intrinsic value as of March 31, 2026 is $4,800 for total outstanding and exercisable warrants, which was based on our estimated fair value of the Class A common stock of $0.02, had all warrant holders exercised their warrants as of that date, net of the aggregate exercise price.